logo

Abiomed Inc. (ABMD)



Trade ABMD now with
  Date
  Headline
10/31/2019 7:29:38 AM Abiomed Q2 Net Income $13.1 Mln Vs. $50.1 Mln Last Year
9/25/2019 7:08:47 AM Abiomed Gets FDA PMA Approval For Impella 5.5 With SmartAssist For Efficacy In Therapy Of Cardiogenic Shock For 14 Days
1/31/2019 7:15:28 AM Abiomed Q3 GAAP Net Income $44.9 Mln Or $0.97/Shr Vs $13.4 Mln Or $0.29/Shr Last Year
1/7/2019 7:10:20 AM Abiomed Reports Q3 Preliminary Revenue Of $200.6 Mln, Increase Of 30%
11/1/2018 7:26:27 AM Abiomed Q2 GAAP Net Income $50.1 Mln Or $1.09/Shr Vs $24.5 Mln Or $0.54/Shr Prior Year
10/9/2018 12:05:15 PM Orchestra BioMed Adds Eric Rose, Jason Aryeh And Gary Pruden To Strategic Advisory Board
5/3/2018 7:28:37 AM Abiomed Q4 Revenue $174 Mln, Up 40%
4/4/2018 8:10:58 AM Abiomed Says European Approval (CE Marking) For Impella 5.5 And First Patient Treated At University Heart Center Hamburg
4/2/2018 8:04:13 AM Abiomed Receives FDA Approval For Impella CP With SmartAssist And Optical Sensor
3/30/2018 9:14:09 AM Abiomed To Appoint Todd Trapp As VP And CFO, Effective April 9
2/13/2018 8:03:12 AM Abiomed Receives Approval For Expanded FDA Indication For Cardiomyopathy With Cardiogenic Shock
2/1/2018 7:10:29 AM Abiomed Q3 Adj. EPS $0.70 Vs $0.34 Last Year
2/5/2016 7:11:18 AM William Blair Is Raising Abiomed Inc. (ABMD) 2017 Rev. Estimate To 426 M From 421 M
2/5/2016 7:11:00 AM William Blair Is Increasing Abiomed Inc. (ABMD) 2016 Rev. Estimate To 326.1 M From 323.8 M
2/5/2016 7:09:52 AM William Blair Is Raising Abiomed Inc. (ABMD) 2016 Estimate To 0.81 From 0.69
1/12/2016 7:22:04 AM William Blair Is Raising Abiomed Inc. (ABMD) 2017 Rev. Estimate To 420.9 M From 386.4 M
  
 
>